Healthcare sector may offset 30% margin cap on cancer drug price through cost cuts, procedure price hikes: Jefferies

New Delhi [India], October 9 (ANI): The healthcare sector may be able to limit the impact of the government’s decision to cap trade margins on non-scheduled anti-cancer drugs through cost rationalisation and gradual increases in procedure prices, according to a report by Jefferies.